Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040562

President and CEO sold 30,766 shares at an average $1.65 ($50,835)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Sale : show line 1 in the form −21,432 $1.65 $35,406 685,239 D
2023-08-16 Sale : show line 2 in the form −9,334 $1.65 $15,429 675,905 D
Open-market sales · 30,766 sh · avg $1.65 · $50,835
Loading xslF345X05/form4.xml…